Edition:
United Kingdom

People: Dicerna Pharmaceuticals Inc (DRNA.OQ)

DRNA.OQ on NASDAQ Stock Exchange Global Select Market

13.40USD
12 Nov 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$13.40
Open
$14.60
Day's High
$14.60
Day's Low
$13.20
Volume
126,587
Avg. Vol
187,518
52-wk High
$17.96
52-wk Low
$6.81

Kolchinsky, Peter 

Dr. Peter Kolchinsky, Ph.D., is Independent Director of the Company. Dr. Kolchinsky is a founding partner and portfolio manager at RA Capital, where he has been since September 2004. He is active in both public and private investments across the pharmaceutical, medical devices, diagnostics and life-science tools industries. Dr. Kolchinsky authored the e-book “The Entrepreneur’s Guide to a Biotech Startup”. Dr. Kolchinsky currently also serves as a member of the boards of directors of Lantos Technologies, Inc., Wave Life Sciences, Adeo Health Science, Inc., Sojournix, Inc., Ivantis, Inc., and Medeor Therapeutics, Inc. In the past, Dr. Kolchinsky served on the Board of Global Science and Technology for the National Academies of Sciences. He received a Ph.D. in virology from Harvard University and a bachelor’s degree from Cornell University. The nominating and corporate governance committee believes that Dr. Kolchinsky’s experience as a venture capital investor in and director of a number of healthcare and life science companies provides him with the qualifications and skills to serve as a member of our board of directors.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 100,631
Fiscal Year Total, USD 100,631

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Madden

149,156

Douglas Fambrough

1,237,030

John Green

--

Bob Brown

722,125

Theodore Ashburn

--

Pankaj Bhargava

2,968,670
As Of  31 Dec 2017